Dr Coremans Laura, gastro-enteroloog
ActiveSummary
Dr Coremans Laura, gastro-enteroloog has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €99k and a net result of €79k. Its solvency ranks better than 42% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
92
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100▲+13
Solvency84▲+43
Growth78
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9k at 30 days acceptable
Liquidity ample (current ratio 2.8 against 1.05 in 2023; short-term debt: 24.9% and cash: 69.6% of total assets), and 40.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 24-07-2025, 7 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
not confirmed
2024
7 d early
2023
14 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€99k▲ 398%
2023 · €20k
2023: €20k
2023 → 2024
Total assets
€168k▲ 38.0%
2023 · €122k
2023: €122k
2023 → 2024
Net result
€79k▲ 355%
2023 · €17k
2023: €17k
2023 → 2024
Working capital
€75k▲ 2,485%
2023 · €3k
2023: €3k
2023 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20232024Trend
Equity€20k-€99k▲ 398%
Operating result€24k-€102k▲ 326%
Net result€17k-€79k▲ 355%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result rises in 2024; 2024 is 326% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €168k
Fixed assets
€51k ▼ 6.6%
Current assets
€117k ▲ 74.6%
Equity and liabilities €168k
Equity
€99k ▲ 398%
Debt
€69k ▼ 32.5%
Debt's share of the balance-sheet total falls from 83.6% to 40.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€116k▲
2023 · €33k
Cash flow
€94k▲
2023 · €27k
Current ratio
2.80▲
2023 · 1.05
Debt to equity
0.69▼
2023 · 5.11
ROE
79.9%▼
2023 · 87.5%
ROA
47.2%▲
2023 · 14.3%
Interest coverage
76.55▲
2023 · 21.59
Debt ≤ 1 year
€42k▼
2023 · €64k
Debt > 1 year
€27k▼
2023 · €37k
Income taxes
€21k▲
2023 · €5k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 42 lines
Balance sheet
Code20232024
Assets
Total assets20/58€122k€168k▲
Formation expenses20€165€0▼
Fixed assets21/28€55k€51k▼
Tangible fixed assets22/27€55k€51k▼
Plant, machinery and equipment23-€4k
Furniture and vehicles24€55k€47k▼
Current assets29/58€67k€117k▲
Amounts receivable within one year40/41€2k€0▼
Trade receivables40€2k€0▼
Cash at bank and in hand54/58€21k€117k▲
Deferred charges and accrued income490/1€44k€60▼
Equity and liabilities
Total equity and liabilities10/49€122k€168k▲
Equity10/15€20k€99k▲
Contributions10/11€3k€3k=
Reserves13€17k€97k▲
Distributable reserves133€17k€97k▲
Amounts payable17/49€102k€69k▼
Amounts payable after more than one year17€37k€27k▼
Financial debts170/4€37k€27k▼
Amounts payable within one year42/48€64k€42k▼
Current portion of amounts payable after more than one year42€10k€10k▲
Trade debts44€137€428▲
Suppliers440/4€137€428▲
Taxes, remuneration and social security45€7k€27k▲
Taxes450/3€7k€27k▲
Other amounts payable47/48€47k€4k▼
Accrued charges and deferred income492/3€366€0▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€14k▲
Other operating charges640/8€348€674▲
Gross operating margin9900€34k€117k▲
Operating profit (loss)9901€24k€102k▲
Financial income75/76B€0€0▼
Recurring financial income75€0€0▼
Financial charges65/66B€2k€2k▼
Recurring financial charges65€2k€2k▼
Profit (loss) for the period before taxes9903€22k€100k▲
Income taxes67/77€5k€21k▲
Profit (loss) for the period9904€17k€79k▲
Profit (loss) for the period to be appropriated9905€17k€79k▲
Appropriation of the result
Profit (loss) to be appropriated9906€17k€79k▲
Transfer to equity691/2€17k€79k▲
To other reserves6921€17k€79k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
24-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity triplescurrent ratio 2.80
Current ratio from 1.05 to 2.80; short-term debt falls from €64k to €42k.
17-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2023
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Hortensiastraat 299000 GentGround area
1.9 ha
Building footprint
1.0 ha
Volume, LiDAR
132,368 m³
2 parcels, Flanders · tallest building 27.4 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Dr Coremans Laura, gastro-enteroloog
since 20232.341.437.666
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44021A1459/00X000 | Flanders | 1.9 ha | 1 · 1.0 ha | 27.4 m · 5 fl. |
| 44810K0206/00Z004 | Flanders | 80 m² | 1 · 64 m² | 12.0 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
GYNIM
BE 0449.783.951
Mechelen · Eq €99,345
YAPAD MEDICAL
BE 1015.747.376
Verlaine · Eq €99,286
AnesTHeezy
BE 1016.779.239
Wezembeek-Oppem · Eq €99,274
Société médicale CORMANN
BE 0810.209.029
Sprimont · Eq €99,213
VAN SURGE
BE 1000.225.002
Fléron · Eq €99,532
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,290 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded10-02-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.